15 results

• Little Known About Breaking Teens’ JUUL Addictions, FDA Told At Hearing

  January 22, 2019

  Irvin Jackson

  Participants at a recent FDA hearing said there is little data on whether smoking cessation drugs like Chantix and Zyban would be useful in treating teen electronic cigarette addictions.

• Parkinson’s Risk Linked to Cymbalta, Celexa, Similar Antidepressants: Study

  July 12, 2018

  Irvin Jackson

  A new study links a number of antidepressants, including Celexa, Cymbalta, Lexapro and Zoloft, to an increased risk of Parkinson's disease and other movement disorders.

• Chantix, Zyban Heart Risks Questioned In New Study

  April 12, 2018

  Irvin Jackson

  A new study appears to contradict previous findings indicating that Chantix and similar smoking cessation drugs carried an increased risk of heart problems.

• Chantix Heart Risks Highlighted in New Study

  December 22, 2017

  Austin Kirk

  A new study warns that Chantix may increase the risk of heart problems, but carries low to no risk of neuropsychiatric side effects.

• Abilify Provides Only “Modest” Effects In Treating Depression: Study

  July 14, 2017

  Irvin Jackson

  The benefits of Abilify to treat people suffering from depression are modest at best and come with an increased risk of adverse events, according to the findings of a new study.

• Suicide Black Box Warning Removed from Chantix, Zyban

  December 19, 2016

  Irvin Jackson

  The FDA has removed a black box warning on mental health side effects from Chantix and Zyban labels, saying an industry-run clinical trials show that the effects rarely result in serious injury.

• Panel Recommends Removing Chantix Box Warning Despite Concerns By ISMP, Public Citizen and FDA Reviewers

  September 15, 2016

  Irvin Jackson

  In a narrow vote, an FDA advisory panel has voted to recommend removing Chantix psychological side effects black box warnings from the smoking cessation drug, even though the FDA's own reviewers and consumer watchdog groups raise questions about the validity of the new data provided by an industry-backed study.

• Contrave Heart Benefits Are Unproven, FDA Restrictions Should be Added to Obesity Drug: Editorial

  March 11, 2016

  Irvin Jackson

  The new weight loss drug Contrave is under close scrutiny over a failed clinical trial whose results were prematurely released, improperly suggesting it had cardiovascular benefits.

• Anti-Smoking Drug Suicide Risks Questioned by New Study

  October 15, 2013

  Irvin Jackson

  Researchers found no evidence that side effects of the smoking cessation drugs Chantix, Wellbutrin or Zyban increase the risk of suicide in a new study.

• Nursing Home Falls Linked to Antidepressants: Study

  July 27, 2011

  Staff Writers

  The side effects of Wellbutrin, Zyban, Effexor and similar drugs could increase the risk of nursing home falls, according to...